---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-029936"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:08:34.353254+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ChromaDex CFO Brianna Gerber resigns effective July 12; consulting transition through Aug 12

## Summary
- CFO & CAO Brianna Gerber resigns effective July 12, 2024; company beginning search for replacement.
- Post-resignation consulting agreement through Aug 12, 2024; $1,000 consulting fee.
- Outstanding stock options and RSUs continue to vest during consulting period per existing equity plan terms.
- Gerber confirms resignation is without Good Reason; no severance benefits under employment agreement.

## SEC filing metadata
- accession: 0001628280-24-029936
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828024029936/0001628280-24-029936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828024029936/cdxc-20240619.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-029936
- JSON: https://secwatch.observer/filing/0001628280-24-029936.json
- Plain text: https://secwatch.observer/filing/0001628280-24-029936.txt

## Key facts
- Executive change
  Brianna Gerber departed as Chief Financial Officer and Chief Accounting Officer at Niagen Bioscience, Inc..
  - Action: resigning
  - Role: Chief Financial Officer and Chief Accounting Officer
  source text: On June 19, 2024, Brianna Gerber, the Chief Financial Officer and Chief Accounting Officer of ChromaDex Corporation (the “Company”), informed the Company that she will be resigning from her roles with the Company, effective July 12, 2024 (the “Separation Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1386570/000162828024029936/0001628280-24-029936-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.